- Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
Daniele Fanale et al, 2022, Frontiers in Oncology CrossRef - Strategies for five tumour markers in the screening and diagnosis of female breast cancer
Jun Luo et al, 2023, Frontiers in Oncology CrossRef - Prognostic Value of Elevated Pre-treatment Serum CA-125 in Epithelial Ovarian Cancer: A Meta-Analysis
Qingyi Wang et al, 2022, Frontiers in Oncology CrossRef